Skip to main content
SpringerLink
Log in

Evaluation and Treatment of Low Responders in Assisted Reproductive Technology: A Challenge to Meet

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose: To investigate the various methods of evaluationand treatment of patients with a low response to controlledovarian hyperstimulation in assisted reproductive technologies (ART). Methods: Review and analysis of relevant studies publishedin the last decade, identified through the literature and Medlinesearches. Results: While a universally accepted definition for lowresponders is still lacking, these patients are reported torepresent about 10% of the ART population. Several ovarianreserve screening techniques have been proposed; however,currently the best-characterized and most sensitive screeningtools available are the basal day 3 serum follicle-stimulatinghormone level and the clomiphene citrate challenge test.When abnormal, these tests allow physicians to counselpatients that their prognosis for conception is poor. Althoughthe presence of a normal result does indicate better long-termchances for conception, an age-related decline in fecundityremains and patient age should still be considered whencounseling patients with normal screening results. Severalstimulation protocols have been applied in the low-responsegroup with varying success. Recent studies show that theuse of a minidose gonadotropin-releasing hormone-agonistprotocol may result in significantly decreased cycle cancellationsas well as increased clinical and ongoing pregnancies,and thus is proposed as a first-line therapy. Studies evaluatingsupplementary forms of treatment to the ovulation inductionregimen show improved outcome when pretreating withoral contraceptives, whereas there seems to be no benefitfrom cotreatment with growth hormone or glucocorticoids.Blastocyst culture and transfer and assisted hatching in lowresponders are still under evaluation, whereas natural cyclein vitro fertilization may be used in cases of repeated failuresas a last option before resorting to oocyte donation or adoption.Future possible forms of treatment like in vitro maturationof immature human oocytes, cytoplasm, and nucleartransfer currently are experimental in nature and their efficacyhas still to be proven.Conclusions: The evaluation and treatment of low respondersin ART remains a challenge. Understanding of the underlyingetiology and pathophysiology of this disorder may helpthe clinician to approach it successfully.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Pellicer A, Lightman A, Diamond MP, Russell JB, DeCherney AH: Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 1987;47:812–815

    Google Scholar 

  2. Laufer N, Navot D: Human in vitro fertilization. In AH DeCherney (ed), Reproductive Failure, 1st ed. New York, Churchill Livingstone, 1986, pp. 219–246

    Google Scholar 

  3. Garcia J, Jones GS, Acosta AA, Wright GL Jr: Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Fertil Steril 1983;39:174–179

    Google Scholar 

  4. Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A, Laufer N: Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril 1998;69:1001–1004

    Google Scholar 

  5. Muasher SJ. Controversies in assisted reproduction: Treatment of low responders. J Assist Reprod Genet 1993;10:112–114

    Google Scholar 

  6. Jacobs SL, Metzger DA, Dodson WC, Haney AF: Effect of age on response to human menopausal gonadotropin stimulation. J Clin Endocrinol Metab 1990;71:1525–1530

    Google Scholar 

  7. Cameron IT, O'Shea FC, Rolland JM, Hughes EG, De Kretser DM, Healy DL: Occult ovarian failure:Asyndrome of infertil-ity, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 1988;67:1190–1194

    Google Scholar 

  8. Pellicer A, Ballester MJ, Serrano MD, Mir A, Serra-Serra V, Remohi J, Bonilla-Musoles MF: Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels. Hum Reprod 1994;9:806–811

    Google Scholar 

  9. Wallach EE: Pitfalls in evaluating ovarian reserve. Fertil Steril 1995;63:12–14

    Google Scholar 

  10. Federation CECOS, Schwartz D, Mayaux MJ: Female fecunin dity as a function of age: Results of an artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med 1982;306:404–406

    Google Scholar 

  11. Templeton A, Morris JK, Parslow W: Factors that affect outcome of in-vitro fertilization treatment. Lancet 1996;348:1402–1406

    Google Scholar 

  12. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF: Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342–1346

    Google Scholar 

  13. Lass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RM: One thousand initiated cycles of in vitro fertilization in women > or 5 40 years of age. Fertil Steril 1998;70:1030–1034

    Google Scholar 

  14. Human Fertilisation and Embryology Authority (HFEA): 1998 Annual report and accounts. London, England, HFEA, 1998

    Google Scholar 

  15. Society for Assisted Reproductive Technology, the American Society for Reproductive Medicine: Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1999;71:798–807

    Google Scholar 

  16. Toner JP, Philput CB, Jones GS, Muasher SJ: Basal folliclestimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784–791

    Google Scholar 

  17. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651–654

    Google Scholar 

  18. Lenton E, Sexton L, Lee S, Cooke I: Progressive changes in LH and FSH and LH:FSH ratio in women throughout reproductive life. Maturitas 1988;10:35–43

    Google Scholar 

  19. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L: An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996;65:588–593

    Google Scholar 

  20. Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ: Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136–1140

    Google Scholar 

  21. Licciardi FL, Liu HC, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991–994

    Google Scholar 

  22. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 1989;2:645–647

    Google Scholar 

  23. Tanbo T, Dale PO, Lunde O, Norman N, Abyholm T. Prediction of response to controlled ovarian hyperstimulation: a gonadocomparison of basal and clomiphene citrate-stimulated folli-cle-stimulating hormone levels. Fertil Steril 1992;57:819–824

    Google Scholar 

  24. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53:295–301

    Google Scholar 

  25. Tanbo T, Dale PO, Abyholm T, Stokke KT: Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/ human menopausal gonadotrophin-stimulated cycles for in vitro fertilization. Hum Reprod 1989;6:647–650

    Google Scholar 

  26. Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ: The gonadotropin-releasing hormone agonist stimulation test-A sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 1991;56:711–717

    Google Scholar 

  27. Scott RT Jr, Hofmann GE: Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1–11

    Google Scholar 

  28. Society for Assisted Reproductive Technology, the American Fertility Society: Assisted reproductive technology in the United States and Canada: 1992 results generated from the American Fertility Society/Society for Assisted Reproductive Technology Registry. Fertil Steril 1994;62:1121–1128

    Google Scholar 

  29. Zaidi J, Barber J, Kyei-Mensah A, Bekir J, Campbell S, Tan SL: Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 1996;88:779–784

    Google Scholar 

  30. Oyesanya O, Parsons JH, Collins WP, Campbell S: Prediction of oocyte recovery rate by transvaginal ultrasonography and color Doppler imaging before human chorionic gonadotropin administration in in vitro fertilization cycles. Fertil Steril 1996;65:806–809

    Google Scholar 

  31. Brown JM, Schwartz LB, Olive D, Lange R, Laufer N, Taylor KJW: Evaluation of Doppler ultrasonography as a means of monitoring in vitro fertilization and embryo transfer cycles: Preliminary results and findings. J Ultrasound Med 1997;16:411–416

    Google Scholar 

  32. Weiner Z, Thaler I, Levron J, Lewit N, Itskowitz-Eldor J: Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: Correlation with the number of follicles and steroid hormone levels. Fertil Steril 1993;59:743–749

    Google Scholar 

  33. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH: Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998;69:505–510

    Google Scholar 

  34. Bonilla-Musoles F, Raga F, Osborne NG: Three-dimensional ultrasound evaluation of ovarian masses. Gynecol Oncol 1995;59:129–135

    Google Scholar 

  35. Bonilla-Musoles F, Raga F, Osborne NG, Pellicer A, Blanes J: Use of three-dimensional ultrasound in reproductive medicine. Assist Reprod Rev 1995;5:170–188

    Google Scholar 

  36. Pellicer A, Ardiles G, Neuspiller F, Remohi J, Simon C, Bonilla-Musoles F: Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998;70:671–675

    Google Scholar 

  37. Agnani G, Joanne CH, Oudghiri F, Benoit S, Gay C, Roux CH: Ultrasound evaluation of the follicular pool in the detection of poor responders. Hum Reprod 1997;12(suppl. 1):216

    Google Scholar 

  38. Tummon IS, Daniel SAJ, Kaplan BR, Nisker JA, Yuzpe AA: Randomized, prospective comparison of luteal leuprolide acetion tate and gonadotropins versus clomiphene citrate and gonadocomparison tropins in 408 first cycles of in vitro fertilization. Fertil Steril 1992;58:563–568

    Google Scholar 

  39. Dor J, Ben-Shlomo I, Levran D, Rudak E, Yunish M, Mashiach S: The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization. Fertil Steril 1992;58:986–990

    Google Scholar 

  40. Benadiva CA, Davis O, Kligman I, Liu HC, Rosenwaks Z: Clomiphene citrate and hMG: An alternative stimulation protocol for selected failed in vitro fertilization patients. J Assist Reprod Genet 1995;12:8–12

    Google Scholar 

  41. Ben-Rafael Z, Feldberg D: The poor-responder patient in an in vitro fertilization-embryo transfer program. J Assist Reprod Genet 1993;10:118–120

    Google Scholar 

  42. Pantos C, Thornton SJ, Speirs AL, Johnston I. Increasing the human menopausal gonadotropin dose-Does the response really improve? Fertil Steril 1990;53:436–439

    Google Scholar 

  43. Awonuga AO, Nabi A: In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation. J Assist Reprod Genet 1997;14:503–507

    Google Scholar 

  44. Scott RT: Evaluation and treatment of low responders. Semin Reprod Endocrinol 1996;14:317–337

    Google Scholar 

  45. Laufer N, DeCherney AH, Haseltine FP, Dumolin JC: The use of high-dose human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril 1982;38:734–741

    Google Scholar 

  46. Jones HW Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14–21

    Google Scholar 

  47. Hofmann GE, Toner JP, Muasher SJ, Jones GS: High-dose follicle-stimulating (FSH) ovarian stimulation in low responder patients for in vitro fertilization. J In Vitro Fertil Embryo Transfer 1989;6:285–289

    Google Scholar 

  48. McKenna KM, Foster P, McBain J, Martin M, Johnston W: Combined treatment with gonadotropin releasing hormone agonist and gonadotropins in poor responders to hyperstimula-tion for in vitro fertilization (IVF): Clinical and endocrine results. Aust NZ J Obstet Gynecol 1989;29:428–432

    Google Scholar 

  49. Karande VC, Jones GS, Veeck LL, Muasher SJ: High-dose follicle stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril 1990;53: 486–489

    Google Scholar 

  50. Stadmauer L, Ditkoff EC, Session D, Kelly A: High dosages of gonadotropins are associated with poor pregnancy out-comes after in vitro fertilization-embryo transfer. Fertil Steril 1994;61:1058–1064

    Google Scholar 

  51. Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH: High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization out-come. Fertil Steril 1996;65:961–965

    Google Scholar 

  52. Rombauts L, Suikkari AM, MacLachian V, Trounson AO, Healy DL: Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril 1998;69:665–669

    Google Scholar 

  53. Frydman R, Parneix I, Belaisch-Allart J, Forman R, Hazout A, Fernandez H, Testart J: LHRH agonist in IVF: Different methods of utilization and comparison with previous ovulation stimulation treatments. Hum Reprod 1988;3:559–561

    Google Scholar 

  54. Remorgida V, Anserini P, Croce S, Costa M, Ferraiolo A, Centonze A, Gaggero G, Capitanio GL: The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program. J In Vitro Fertil Embryo Transf 1989;6:76–80

    Google Scholar 

  55. Smitz J, Ron-El R, Tarlatzis BC: The use of gonadotropin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centers. Hum Reprod 1992;7(suppl. 1):49–66

    Google Scholar 

  56. Toth TL, Awwas JT, Veeck LL, Jones HW Jr, Muasher SJ: Suppression and flare regimens of gonadotropin-releasing hormone agonist: Use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med 1996;41:321–326

    Google Scholar 

  57. Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, Masson GM: Comparison of “poor” responders with “good” responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 1991;7:918–921

    Google Scholar 

  58. Tasdemir M, Tasdemir I, Kodama H, Fukuda J, Tanaka T: Short protocol of gonadotropin releasing hormone agonist administration gave better results in long protocol poor responders in IVF-ET. J Obstet Gynaecol Res 1996;22:73–77

    Google Scholar 

  59. Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, Fernandez H, Frydman H: A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle stimulating hormone concentrations on day 3. Hum Reprod 1996;11:1169–1172

    Google Scholar 

  60. Padilla SL, Dugan K, Maruschak V, Shaika S, Smith RD: Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril 1996;65:796–799

    Google Scholar 

  61. Yang JH, Wu MY, Chao KH, Chen SU, Ho HN, Yang YS: Long GnRH-agonist protocol in an IVF program: Is it appropriate for women with normal FSH levels and high FSH/LH ratios? J Reprod Med 1997;42:663–668

    Google Scholar 

  62. Gelety TJ, Pearlstone AC, Surrey ES: Short-term endocrine responses to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normal cycling women. Fertil Steril 1995;64:1074–1080

    Google Scholar 

  63. Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N. Limited success using the “flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril 1997;67:900–903

    Google Scholar 

  64. Laufer N, Simon A, Hurwitz A, Glatstein IZ: In vitro fertilization. In MM Seibel (ed), Infertility: A Comprehensive Text, 2nd ed. Stamford, CT; Appleton & Lange, 1996, pp 703–749

    Google Scholar 

  65. Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, Muasher SJ: Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998;69:826–830

    Google Scholar 

  66. Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;61:880–885

    Google Scholar 

  67. Feldberg D, Fahri J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343–346

    Google Scholar 

  68. Surrey ES, Joann B, Hill DM, Ramsey J, Surrey MW: Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419–424

    Google Scholar 

  69. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L: Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93–97

    Google Scholar 

  70. Owen EJ, West C, Mason BA, Jacobs HS: Co-treatment with growth hormone of sub-optimal responders in IVF-ET. Hum Reprod 1991;6:524–528

    Google Scholar 

  71. Homburg R. Growth hormone and fertility-Clinical studies. Horm Res 1996;45:81–85

    Google Scholar 

  72. Volpe A, Coukos G, Barreca A, Artini PG, Ginuto F, Giordano G, Genazzani AR: Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation. Gynecol Endocrinol 1989;3:125–133

    Google Scholar 

  73. Bergh C, Hillensjo T, Wikland M, Nilsson L, Borg G, Hamberger L: Adjuvant growth hormone treatment during in vitro fertilization: A randomized, placebo-controlled study. Fertil Steril 1994;62:113–120

    Google Scholar 

  74. Hughes SM, Huang ZH, Morris ID, Matson PL, Buck P, Lieberman BA: A double-blind cross-over study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in vitro fertilization. Hum Reprod 1994;9:13–18

    Google Scholar 

  75. Suikkari AM, MacLachlan V, Koistinen R, Seppala M, Healy DL: Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril 1996;65:800–805

    Google Scholar 

  76. Busacca M, Fusi FM, Brigante C, Bonzi V, Gonfiantini C, Vignali M, Ferrari A: Use of growth hormone-releasing factor in ovulation induction in poor responders. J Reprod Med 1996:41:699–703

    Google Scholar 

  77. Bider D, Blankstein J, Levron J, Tur-Kaspa I: Gonadotropins and glucocorticoid therapy for “low responders”-A controlled study. J Assist Reprod Genet 1997;14:328–331

    Google Scholar 

  78. Gonen Y, Jacobson W, Casper RF: Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril 1990;53:282–287

    Google Scholar 

  79. Fisch B, Royburt M, Pinkas H, Avrech OM, Goldman GA, Bar J, Tadir Y, Ovadia J: Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills. Isr J Med Sci 1996;32:1172–1176

    Google Scholar 

  80. Lindheim SR, Barad DH, Witt B, Ditkoff E, Sauer MV: Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet 1996;13:745–747

    Google Scholar 

  81. Lindheim SR, Vidali A, Ditkoff E, Sauer MV, Zinger M: Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval. J Assist Reprod Genet 1997;14:174–177

    Google Scholar 

  82. Scholtes M, Zeilmaker G: A prospective randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization. Fertil Steril 1996;65:1245–1248

    Google Scholar 

  83. Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB: Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril 1998;69:84–88

    Google Scholar 

  84. Cohen J, Inge KL, Suzmann M, Wiker SR, Wright G: Video-cinematography of fresh and cryopreserved embryos: A retro-spective analysis of embryonic morphology and implantation. Fertil Steril 1989;51:820–827

    Google Scholar 

  85. Schoolcraft WB, Schlenker T, Gee M, Jones GS, Jones HW Jr: Assisted hatching in the treatment of poor prognosis in vitro fertilization candidates. Fertil Steril 1994;62:551–554

    Google Scholar 

  86. Stein A, Rufas O, Amit S, Avrech O, Pinkas H, Ovadia J, Fisch B: Assisted hatching by partial zona dissection of human pre-embryos in patients with recurrent implantation failure after in vitro fertilization. Fertil Steril 1995;63:838–841

    Google Scholar 

  87. Magli MC, Gianaroli L, Ferraretti AP, Fortini D, Aicardi G, Montanaro N: Rescue of implantation potential in embryos with poor prognosis by assisted zona hatching. Hum Reprod 1998;13:1331–1335

    Google Scholar 

  88. Hellebaut S, De Sutter P, Dozortsev D, Onghena A, Qian C, Dhont M: Does assisted hatching improve implantation rates after in vitro fertilization or intracytoplasmic sperm injection in all patients? A prospective randomized study. J Assist Reprod Genet 1996;13:19–22

    Google Scholar 

  89. Tucker MJ, Morton PC, Wright G, Ingargiola PE, Sweitzer CI, Elsner CW, Mitchell-Leef DE, Massey JB: Enhancement of outcome from intracytoplasmic sperm injection: Does coculture or assisted hatching improve implantation rates? Hum Reprod 1996;11:2434–2437

    Google Scholar 

  90. Lanzendorf SE, Nechrini F, Mayer JF, Oehninger S, Muasher SJ: A prospective, randomized, double-blind study for the evaluation of assisted hatching in patients with advanced maternal age. Hum Reprod 1998;13:409–413

    Google Scholar 

  91. Moreno C, Ruiz A, Simon C, Pellicer A, Remohi J: Intracy-toplasmic sperm injection as a routine indication in low responder patients. Hum Reprod 1998;13:2126–2129

    Google Scholar 

  92. Palermo GD, Cohen J, Rosenwaks Z: Intracytoplasmic sperm injection: A powerful tool to overcome fertilization failure. Fertil Steril 1996;65:899–908

    Google Scholar 

  93. Wiemer KE, Cohen J, Tucker MJ, Godke RA: The application of co-culture in assisted reproduction: 10 years of experience with human embryos. Hum Reprod 1998;13:226–238

    Google Scholar 

  94. Cohen J, Scott R, Alikani M, Schimmel T, Munne S, Levron J, Wu L, Brenner C, Warner C, Willadsen S: Ooplasmic transfer in mature human oocytes. Mol Hum Reprod 1998;4:269–280

    Google Scholar 

  95. Keefe DL, Niven-Fairchild T, Powell S, Buradagunta S: Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women. Fertil Steril 1995;64:577–583

    Google Scholar 

  96. Schmidt-Sarosi C: Infertility in the older woman. Clin Obstet Gynecol 1998;41:940–950

    Google Scholar 

  97. Cha KY, Koo JJ, Choi DH, Han SY, Yoon TK: Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991;55:109–113

    Google Scholar 

  98. Trounson AO, Wood C, Kausche A: In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 1994;62:353–362

    Google Scholar 

  99. Russell JB: Immature oocyte retrieval combined with in-vitro oocyte maturation. Hum Reprod 1998 (suppl. 3); 13:63–70

  100. Van Kooij, RJ, Looman CWN, Habbema JDF, Dorland M, Te Velde ER: Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril 1996;66:769–775

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Hebrew University, Hadassah Medical Center, Jerusalem, 91120, Israel

    Sozos J. Fasouliotis, Alex Simon & Neri Laufer

Authors
  1. Sozos J. Fasouliotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neri Laufer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fasouliotis, S.J., Simon, A. & Laufer, N. Evaluation and Treatment of Low Responders in Assisted Reproductive Technology: A Challenge to Meet. J Assist Reprod Genet 17, 357–373 (2000). https://doi.org/10.1023/A:1009465324197

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009465324197

Search

Navigation